Poolbeg Pharma Ltd. (GB:POLB) has released an update.
Poolbeg Pharma is set to make a virtual presentation at the H.C. Wainwright 26th Annual Global Investment Conference on September 9-11, 2024, showcasing its focus on developing innovative medicines for diseases with unmet medical needs. The event offers an opportunity for in-person investor meetings in New York, scheduled through their representative or directly via Poolbeg’s contact. The company is advancing clinical programs in areas such as cancer immunotherapy, infectious diseases, and metabolic conditions, leveraging a cost-effective development approach and AI-driven research.
For further insights into GB:POLB stock, check out TipRanks’ Stock Analysis page.
